Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	1279.77	575.48	41.71
Graham Fair Price	-54.53	16.49	36.27
PEG	-90.16	0.12	-1.18
Price/Book	788.87	3.19	0.36
Price/Cash Flow	inf	0.00	179.10
Prices/Earnings	-37.49	8.43	13.49
Price/Sales	-50.26	9.42	18.94
Price/FCF	inf	0.00	179.10
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	0.00	1.00	1.00
Operating Margin	-99.93	< 0.005	0.47
ROA	1851.86	< 0.005	< 0.005
ROE	< 0.005	0.09	1321.91
ROIC	< 0.005	< 0.005	-99.28
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	4.85	-0.50	861.54
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.13	-1.00	-642.16
EPS QOQ	-0.11	0.73	535.08
FCF QOQ	0.09	-1.00	1013.15
Revenue QOQ	0.35	1.16	231.20
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	48.34	0.00	inf
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.15	0.54	258.35
Quick Ratio	-0.97	0.00	inf
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	93.75	11.31	-87.94
Cash	-2.47	0.00	inf
Capex	0.00	0.00	0.00
Free Cash Flow	0.19	0.00	inf
Revenue	1.78	3.83	115.49
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.60	0.00	inf
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	5.35	164.59	2979.20
Naive Interpretation	Member

06 - Financial Health · Bad

Rating